Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

REALISTIC: Protocol for an Observational Study in High Risk Patients Switched From Higher Doses of Other Statins to Crestor on the Percentage of Patients Reaching the New EAS LDL-C Target Goal

NCT00240344 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.

NCT NCT00240344
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00240344 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
REALISTIC: Protocol for an Observational Study in High Risk Patients Switched From Higher Doses of Other Statins to Crestor on the Percentage of Patients Reaching the New EAS LDL-C Target Goal
Lead sponsor
AstraZeneca
Phase
Observational
Overall status
Completed
Start date
September 30, 2004
Completion date
February 29, 2008
Enrollment
2,650 (actual)
Sites
75

Conditions

As the registry lists them; a condition with its own page is linked.

hypercholesterolemia